Antibody discovery companies develop platforms and services for identifying antibodies used in therapeutics, diagnostics and life science research. Their technologies support candidate discovery, screening, optimisation and early development.
This category includes companies working on:
Browse 45 UK antibody discovery companies below.
Target discovery platform and antibody-based therapies for oncology
Oxford BioTherapeutics is an Oxford-based clinical-stage oncology company discovering and developing first-in-class antibody-based cancer therapies. Its proprietary platform identifies novel membrane protein targets directly from patient tumour samples, enabling the development of ADCs, immuno-oncology antibodies,…
Infectious disease antigens and antibodies for diagnostics and research
The Native Antigen Company is a manufacturer of native and recombinant antigens, antibodies, and immunoassays for viral and bacterial infectious disease targets. Products are supplied to IVD manufacturers, pharmaceutical companies, and academic institutions for use in immunoassay development, serology, vaccine…
Chemical reagents and contract manufacturing for pharma and diagnostics supply chains
Biosynth Limited is the UK manufacturing and research entity of Biosynth, a global life sciences reagents and contract development and manufacturing organisation. Its Compton, Berkshire site specialises in complex chemical synthesis including carbohydrates, nucleosides, and enzyme substrates, supplying critical raw…
Benchtop platform for rapid cell-free protein expression and screening
Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening. Its discovery platform integrates cell-free protein synthesis, digital microfluidics, and automated construct screening to deliver soluble, active proteins in under 48 hours. The system is…
AI platform for in silico antibody discovery
Antiverse is a Cardiff-based company using machine learning to identify diverse and rare antibody candidates from next-generation sequencing data of naïve and immune repertoires. Its AI-augmented discovery platform analyses NGS data in silico to shortlist effective and developable antibodies, claiming a tenfold…
Recombinant antibody sequencing, engineering and manufacturing services
Absolute Antibody specialises in recombinant antibody technology, offering sequencing, engineering and production services alongside a catalogue of recombinant antibodies and Fc fusion proteins in a range of formats. The company's ISO 9001:2015-certified manufacturing facility serves pharmaceutical, biotechnology,…
T cell-engaging multispecific antibody fragments for solid tumours
Crescendo Biologics is a clinical-stage biopharmaceutical company developing multispecific therapeutics based on fully human single-domain antibody fragments engineered for enhanced tumour penetration and selective T cell activation within the tumour microenvironment. Its lead programme is in Phase 1b clinical trials…
Custom peptide synthesis, antibodies, and protein analysis services
Alta Bioscience is a manufacturer and accredited analytical laboratory specialising in custom biochemical synthesis and protein analysis services. The company produces custom peptides, peptide libraries, DNA oligonucleotides, and polyclonal and monoclonal antibodies for academic, pharmaceutical, and food industry…
Preclinical CRO delivering integrated drug discovery and development services
Selvita is a contract research organisation providing integrated drug discovery and development services to pharmaceutical and biotechnology companies. The company supports projects from target validation through preclinical candidate nomination, with expertise in medicinal chemistry, pharmacology, DMPK and protein…
Custom recombinant antibody and protein development services
Scotia Biologics is a contract research organisation specialising in custom antibody and recombinant protein development for biomedical researchers and diagnostic developers. Services span antigen design, polyclonal and monoclonal antibody generation via hybridoma and phage display, antibody engineering including…
Integrated outsourced drug discovery and development platform
RxCelerate is a contract research organisation providing fully integrated drug discovery and development services to pharmaceutical and biotech companies. Based at Babraham Research Campus, the company offers end-to-end programme delivery spanning computational design, antibody discovery, medicinal chemistry, in vitro…
AI-driven antibody reagents and diagnostics for research and clinical use
Vertebrate Antibodies is a contract research organisation developing custom monoclonal antibodies, recombinant proteins, and AI-driven diagnostic products for research and clinical applications. Its AI-driven epitope prediction and antigen display platforms enable highly specific antibody generation against novel…
National innovation centre accelerating drug discovery
Medicines Discovery Catapult (MDC) is an independent, not-for-profit national innovation centre that supports UK medicines discovery organisations across the full drug discovery pipeline. MDC provides access to specialist laboratory technologies, computational and AI-driven tools, translational R&D expertise, and…
Global drug discovery and development partnership company
Evotec is a global drug discovery and development company with major UK operations at Milton Park, Abingdon, and Alderley Park, Cheshire. Its Abingdon campus houses over 800 staff spanning target validation, medicinal chemistry, structural biology, in silico design, process development, and biologics manufacturing…
Bispecific antibody platform for cancer immunotherapies
F-star Therapeutics is a clinical-stage biotechnology company developing tetravalent bispecific antibodies for cancer and other serious diseases. Its proprietary platform creates antibodies with four binding sites that simultaneously target two different antigens, enabling focused immune activation in the tumour…
Pre-competitive biologics drug discovery platforms and services for partners
Alloy Therapeutics UK is the Cambridge-based research operation of Alloy Therapeutics, a biotechnology platform company providing pre-competitive drug discovery technologies and services across antibody, TCR, genetic medicine, cell therapy, peptide, and drug delivery modalities. The company offers both discovery…
Recombinant antibodies developed using display technology platforms
Tresars is a developer and manufacturer of synthetic, non-animal-derived recombinant antibodies for life science research. Using phage, yeast, mRNA, and ribosome display technologies, the company selects and affinity-matures antibody clones against customer-specified protein targets without animal immunisation.…
CDMO and CRO for complex biologics and bioconjugate development
Abzena is an integrated CDMO and CRO specialising in complex biologics and bioconjugates, with cGMP facilities across the United States and a research presence in Cambridge, UK. Its services span antibody discovery, cell line development, bioconjugation and GMP manufacturing across monoclonal antibodies, antibody-drug…
Biological raw materials and IVD test platforms for diagnostics
BBI Solutions is a global manufacturer of biological raw materials and finished test platforms for the in-vitro diagnostics market. Products include antibodies, antigens, enzymes, gold nanoparticles, and serum and plasma materials used across lateral flow, ELISA, biosensor, and clinical chemistry applications. The…
Contract immunoassay development and bioconjugation services
Fleet Bioprocessing is a Hampshire-based contract development and manufacturing organisation specialising in immunoassay development and bioconjugation. Founded in 2000 by former scientists from Johnson & Johnson and Amersham International, the company provides contract R&D and manufacturing services to diagnostics,…